Evidence-based program and curriculum review and refinement, notably in the E2P PharmD and BPSc degrees, reflecting on the lessons learned through COVID-19 and seeking ways to expand inter-disciplinary education and practicums throughout our portfolio

• Entry-to-Practice PharmD program to better understand the use of AI and how it will affect how program students’ learning and examination experiences (2023 and ongoing).
• Entry-to-Practice PharmD program to re-examine educational leadership roles and descriptions (2025–26).
• Entry-to-Practice PharmD program to review Committee Terms of Reference.
• Enhance the educational value of assessment by renewed emphasis on assessment for learning (2024 and ongoing). Provide best practice guides and the evidential base for the needed changes to the assessment systems of the Faculty education programs.
• Develop new approach to curriculum mapping, potentially using Artificial Intelligence (2026 and beyond).
• Implement changes to all programs identified through ongoing curriculum review activities (2026); this includes full review of the new Graduate Diploma in Pharmacy Leadership (GDPL) program with course coordinators.
• Complete accreditation process for Entry-to-Practice PharmD program (2026).
• Implement Program Evaluation and Quality Assurance Committee (2026).

Graduate Diploma in Pharmacy Leadership (GDPL)

• Launched GDPL program (2024). Completed first cohort of the Graduate Diploma in Pharmacy Leadership; program team reached out to students to gather feedback to review and refine program (2025).

Entry-to-Practice PharmD

• Awarded $72,000 Teaching, Learning, Enhancement Fund (TLEF) for year 1 of a two-year project Hybrid Learning in the Pharmacy Program (HIPP) to support the development of a more permanent hybrid design for the Entry-to-Practice PharmD Program (April 2023). Initial Hybrid Learning Activity (ALA) launched (Sep 2023). The HIPP project was awarded $120,000 in year 2 (2024). Sustainability model for ongoing implementation oversight of ALAs discussed at committee level (Jan 2025). 9 ALAs completed (2025); additional ALAs completed with final funding (2025).
• SPIIF fund approved project to support Minor Ailment Prescribing project to integrate the expanded scope of training into the Entry-to-Practice PharmD curriculum (May 2023); Task Force initiated (June 2023); report delivered Feb 2024; project final report completed (fall 2025).
• Initiated rural elective in the Entry-to-Practice PharmD program (summer 2024).
• PRIDE-RX team (Principal Co-Investigators: Tristan Lai and Alex Tang) received financial support from the UBC Internal Seed Grant Program for Educational Leadership to conduct the study, Promoting 2SLGBTQQIA+ Inclusion, Diversity and Equity in Pharmacy Education (PRIDE-RX). This study, approved by the UBC Behavioral Research Ethics Board, sought to understand the current state of 2SLGBTQ+ health care in pharmacies in BC and highlight priority areas. The study concluded, and preliminary findings were shared with the College of Pharmacists of British Columbia at its April 2023 board meeting. The PRIDE-Rx team received $205,107 funding through UBC TLEF project in 2022/23 and 2023/24. A project summary was presented across UBC (Sep 2024). The work was presented to the Canadian Pharmacists Association (Jan 2025). Approved the elective course "Queering Health" (PHRM331), after its pilot deliveries in fall 2024 and 2023 (fall 2025). Implemented second iteration of PHRM 473 Community Engaged Learning (2SLGBTQ+) practicum with partners: Health Initiative for Men, QMUNITY, and Community-Based Research Centre (fall 2025). The PrideRx website was launched (fall 2025). Received 2025 D2L Innovation Award in Teaching and Learning for PrideRx, a national award for inclusive curriculum innovation (2025).
• SPIIF fund approved "GENRx: Leveraging generative AI technology to enhance virtual patient consultations for pharmacy students" by Jamie Yuen and Fong Chan—awarded $15,000. The project explored how to leverage generative artificial intelligence (AI) technology to enable simulated patient consultations for pharmacy students to practice history taking and documentation, promote active learning and engagement (April 2024). A related extension of this project was awarded $99,967 through the Teaching, Learning, Enhancement Fund (TLEF) for year 1 of a two year project: “GENRx: Generative AI-Enhanced Role-Playing for Pharmacy Education and Physical Examination” (April 2025). GenRx platform showcased at the UBC TEC Expo (Nov 2025).
• Awarded $26,798 through the Teaching, Learning, Enhancement Fund (TLEF) for year 1 of a two year project Remediation Program for Students Experiencing Academic Challenges during Practicum in the Entry-to-Practice PharmD Program (Apr 2023). The project was awarded $13,306 in year 2 (2024).
• Awarded $30,000 through the Teaching, Learning, Enhancement Fund (TLEF) for year 1 of a two year project IMPPaCT Project – Implementing Pharmacy Point of Care Testing Project (April 2023). The project was awarded $19,983 in year 2 (2024).
• Awarded $30,000 through the Teaching, Learning, Enhancement Fund (TLEF) for The BRAIN Project – Building Resources and Accessibility in Neurology for Practical Learning (April 2024). The project was awarded $20,000 in year 2 (2025).
• Awarded $10,000 through the Strategic Equity and Anti-Racism (StEAR) Enhancement Fund for "Accessibility in innovative health pedagogy: electronic health records in teaching and learning (The aEHR project)" (April 2024).
• SPIIF fund approved "Enhancing Pharmacy Education in BC Primary Care: Bridging Experiential Learning Gaps" by Asal Taheri—awarded $15,000. This project aimed to address the gaps in experiential learning for trainee pharmacists within the evolving BC primary care landscape (April 2024); interviews with primary care pharmacists planned for 2025.
• Implemented self-study evaluative review as part of the Entry-to-Practice PharmD accreditation process (Jan 2025); as part of this process conducted a large curriculum mapping project in collaboration with faculty, staff and students (including 2 visiting students from Qatar University) (2025). Submitted accreditation self-study to the Canadian Council for the Accreditation of Pharmacy Programs (CCAPP), which enabled a through review of the Entry-to-Practice PharmD program (Nov 2025).
• Awarded $24,983 through the Teaching, Learning, Enhancement Fund (TLEF) as part of a cross-Faculty initiative for Harmonizing Interprofessional Virtual Teams (HIVE): eEnhancement and integration of innovative interprofessional learning for hybrid care (April 2025); will update UBC Health Interprofessional Education (IPE) health informatics module.
• Awarded $91,215 through the Teaching, Learning, Enhancement Fund (TLEF) for the EMPATH-AI: Generative AI for Enhancing Empathy and Communication Skills in Pharmacy Education project (April 2025).
• Awarded $31,872 through the Teaching, Learning, Enhancement Fund (TLEF) for the AI AM READY: Readying Pharmacy Students for Practice in a World with GenAI project (April 2025).
• Awarded $27,500 through the Teaching, Learning, Enhancement Fund (TLEF) for the Building deep AI-integrated pedagogy using the aEHR project (April 2025).
• Created the first land-based learning elective course (PHRM 300) for the Faculty, rooted in Indigenous cultural practices, with teachings directly connected to nature. This approach emphasizes holistic well-being, integrating cultural teachings from Knowledge Keepers in traditional medicine. Place-based learning draws from the specific local and ecological context, allowing students to explore natural and urban landscapes around them. Course launched for first time (May 2025).

BPSc

• Implemented BPSc Yr4 PHAR courses and graduated the first BPSc program class. Initiated review of program policies and procedures, as well as the first 4 years of the program to identify potential curricular gaps or areas for improvement (2024/2025). Curriculum review underway (2024).
• Internally approved "Co-operative education” course in the BPSc program with plan to implement in 2026W, with first students expected to be admitted to co-op terms in 2027 (Sep 2025).
• Awarded $38,716 through the Teaching, Learning, Enhancement Fund (TLEF) for Statistics Bakers: a Recipe Box for Biostatistics and Critical Appraisal Courses at The University of British Columbia (April 2024).

Cross Program 

• Awarded $10,000 per year through the Universal Design for Learning (UDL) Fellowship program with Robert Pammett as faculty fellow to support the development of a UDL focused curricula in the Faculty (summer 2023); Paolo Tchen was chosen as the 2024 UDL fellow (2024); third fellow Jillian Reardon completed the program (2025); fourth fellow identified for 2026 cohort (2025).
• SPIIF fund approved "Queer Eye for Pharm Sci: Supporting Sexual Orientation, Gender Identity and Expression Integration into Pharmacy Programs" by Tim Lim—awarded $10,000. This project encompassed a two-year professional development endeavour which delivered sequential workshops and related resources to educators of training programs to build capacity in training related to sexual orientation, gender identity and expression (SOGIE) (April 2024). For their work, Tristan Lai and Alex Tang were recipients of the Canadian Foundation for Pharmacy's Wellspring Pharmacy Leadership Award (2024). Workshops delivered in 2024 and 2025.
• Created Office of Educational Assessment (OEA) Strategic Plan to enhance and improve assessment throughout our programs (Sep 2025).
• OETLD implemented two successful pilots of the MobileConnect system, which will be used more broadly across courses going forward (fall 2025).
• Developed and implemented Seatr system to assign or record student location in classrooms and linked to course and student data systems. Developed API access to share across the institution (2020–onwards).